-transparent.png){kind=logo}
During inflammation, polymorphonuclear neutrophils (PMN) are exposed to and influenced by various cytokines, including the chemoattractant interleukin-8 (IL-8). We tested the hypothesis that IL-8 affects apoptosis in PMN. We investigated which IL-8 receptor (RI or RII) might be involved, as well as the role of Bcl-2. Human PMN were isolated and cultured up to 30 hours. Apoptosis was detected by UV and light microscopy, as well as by DNA-fragmentation assay, and quantitated by flow cytometry. Interleukin-8 significantly delayed spontaneous apoptosis at 10, 20, and 30 hours in a dose-dependent fashion. Polymorphonuclear neutrophil treatment with the highest concentration of IL-8 (100 nM) decreased the percentage of apoptotic cells from 2.1 +/- 1.5 to 0.8 +/- 0.2 after 10 hours, from 31 +/- 14 to 8 +/- 5 after 20 hours, and from 47 +/- 15 to 18 +/- 8 after 30 hours of incubation (P < 0.05 for all time points, N = 6). Interleukin-8 also inhibited TNF alpha-mediated PMN apoptosis. Incubation with 20 ng/ml TNF alpha resulted in 23 +/- 6% apoptotic cells at four hours, whereas pretreatment with IL-8 (50 nM) decreased this percentage to 11 +/- 3 (N = 5, P < 0.05). We next studied the role of both types of IL-8 receptors, RI and RII, by comparing the effect of IL-8 and the product of growth-related oncogene alpha (Gro alpha) on PMN cultured for 20 hours. Both IL-8 and Gro alpha attenuated apoptosis, although IL-8 was more effective than Gro alpha. Bcl-2 was detected by intracellular fluorescent antibody cell sorter analysis, Western blot, and reverse transcription-polymerase chain reaction (RT-PCR). Neither resting PMN nor IL-8-treated neutrophils expressed BCL-2 protein, which was readily detected in control cells. Furthermore, we could not detect BCL-2 gene expression by RT-PCR. We conclude that IL-8 prolongs the lifespan of human neutrophils in vitro by delaying apoptosis. This effect may be important for a controlled and effective inflammatory response. The delay in apoptosis can be mediated by the IL-8 RII, while RI may provide an added effect. The actions of IL-8 on apoptosis are Bcl-2 independent.
R Kettritz, and
M L Gaido, and
H Haller, and
F C Luft, and
C J Jennette, and
R J Falk
January 2000,
American journal of physiology. Lung cellular and molecular physiology,
R Kettritz, and
M L Gaido, and
H Haller, and
F C Luft, and
C J Jennette, and
R J Falk
September 1999,
The Journal of laboratory and clinical medicine,
R Kettritz, and
M L Gaido, and
H Haller, and
F C Luft, and
C J Jennette, and
R J Falk
March 2001,
Journal of leukocyte biology,
R Kettritz, and
M L Gaido, and
H Haller, and
F C Luft, and
C J Jennette, and
R J Falk
January 1990,
Progress in clinical and biological research,
R Kettritz, and
M L Gaido, and
H Haller, and
F C Luft, and
C J Jennette, and
R J Falk
March 2010,
American journal of physiology. Cell physiology,
R Kettritz, and
M L Gaido, and
H Haller, and
F C Luft, and
C J Jennette, and
R J Falk
January 1994,
European cytokine network,
R Kettritz, and
M L Gaido, and
H Haller, and
F C Luft, and
C J Jennette, and
R J Falk
February 2002,
The Journal of laboratory and clinical medicine,
R Kettritz, and
M L Gaido, and
H Haller, and
F C Luft, and
C J Jennette, and
R J Falk
May 2006,
The Journal of biological chemistry,
R Kettritz, and
M L Gaido, and
H Haller, and
F C Luft, and
C J Jennette, and
R J Falk
February 1991,
Journal of leukocyte biology,
R Kettritz, and
M L Gaido, and
H Haller, and
F C Luft, and
C J Jennette, and
R J Falk
December 2002,
Experimental dermatology,
